TCEAL5: Key Regulator of Cell Growth and Innovation (G340543)

Target Name: TCEAL5

NCBI ID: G340543

TCEAL5

TCEAL5: Key Regulator of Cell Growth and Innovation

TCEAL5 (Tetrahydroxyprolinealine) is a protein that is expressed in various tissues of the human body. It is a key regulator of cell growth and differentiation, and has been implicated in a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the unique features of TCEAL5 is its ability to interact with a variety of different proteins, including tyrosine, which is a hormone and a key signaling molecule. This interaction between TCEAL5 and tyrosine has important implications for the regulation of cellular processes, including cell growth, differentiation, and inflammation.

In addition to its role in cell signaling, TCEAL5 has also been shown to play a key role in the regulation of cellular DNA replication. This is important because DNA replication is a critical process that is essential for the growth and maintenance of all living organisms.

TCEAL5 has also been shown to interact with the protein p53, which is a well-known tumor suppressor protein that is often mutated in cancer. The interaction between TCEAL5 and p53 suggests that TCEAL5 may be a potential drug target or biomarker for cancer.

Another potential role for TCEAL5 is in the regulation of the immune system. TCEAL5 has been shown to interact with the protein PDGF-BB, which is a key regulator of immune cell development and function. This interaction suggests that TCEAL5 may be involved in the regulation of immune cell responses to infection or disease.

In addition to its potential roles in cell signaling and immune system regulation, TCEAL5 is also of interest as a potential drug target because of its ability to interact with the protein FBN1, which is a protein that is expressed in the blood vessels. The interaction between TCEAL5 and FBN1 suggests that TCEAL5 may be involved in the regulation of blood vessel formation and function, which could have important implications for the development of cardiovascular disease.

Overall, TCEAL5 is a protein that has important implications for a variety of cellular processes in the human body. Its ability to interact with a variety of different proteins, including tyrosine and PDGF-BB, suggests that it may be a potential drug target or biomarker for a variety of diseases. Further research is needed to fully understand the role of TCEAL5 in cellular processes and its potential as a drug target.

Protein Name: Transcription Elongation Factor A Like 5

Functions: May be involved in transcriptional regulation

The "TCEAL5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TCEAL5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets